Telix Pharmaceuticals Limited
General ticker "TLPPF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.9B (TTM average)
Telix Pharmaceuticals Limited does not follow the US Stock Market performance with the rate: -38.1%.
Estimated limits based on current volatility of 1.6%: low 9.42$, high 9.73$
Factors to consider:
- Total employees count: 200000 as of 2024
Short-term TLPPF quotes
Long-term TLPPF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | AUD160.10MM | AUD502.55MM | AUD783.21MM |
| Operating Expenses | AUD252.03MM | AUD450.66MM | AUD701.08MM |
| Operating Income | AUD-91.93MM | AUD51.89MM | AUD82.13MM |
| Non-Operating Income | AUD-6.69MM | AUD-48.80MM | AUD-26.07MM |
| Interest Expense | AUD0.41MM | AUD13.56MM | AUD21.46MM |
| R&D Expense | AUD57.86MM | AUD128.84MM | AUD121.03MM |
| Income(Loss) | AUD-98.62MM | AUD3.09MM | AUD56.06MM |
| Taxes | AUD5.46MM | AUD-2.12MM | AUD6.14MM |
| Profit(Loss)* | AUD-104.08MM | AUD5.21MM | AUD99.84MM |
| Stockholders Equity | AUD80.01MM | AUD148.91MM | AUD568.21MM |
| Inventory | AUD5.77MM | AUD17.31MM | AUD38.14MM |
| Assets | AUD255.35MM | AUD398.30MM | AUD1,516.43MM |
| Operating Cash Flow | AUD-63.97MM | AUD23.88MM | AUD43.03MM |
| Capital expenditure | AUD13.86MM | AUD10.79MM | AUD34.03MM |
| Investing Cash Flow | AUD-17.00MM | AUD-25.49MM | AUD-135.17MM |
| Financing Cash Flow | AUD174.96MM | AUD10.19MM | AUD638.92MM |
| Earnings Per Share** | AUD-0.34 | AUD0.02 | AUD0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.